

Cover Story
Conversation with The Cancer Letter
By Matthew Bin Han Ong
Will an oncologist of the not-so-distant future be able to pull up an image of a tumor biopsy slide on a screen and—without having to order a biomarker test—see the molecular characteristics of the cancer?
By Alexandria Carolan
In Brief


Clinical Roundup


Drugs & Targets


Trending Stories
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- Trump administration announces “major crackdown” on healthcare fraud
- Lou Weiner to step down as director of Georgetown’s Lombardi CCC after 18 years












